Literature DB >> 14504330

Rapsyn mutations in hereditary myasthenia: distinct early- and late-onset phenotypes.

G Burke1, J Cossins, S Maxwell, G Owens, A Vincent, S Robb, M Nicolle, D Hilton-Jones, J Newsom-Davis, J Palace, D Beeson.   

Abstract

Rapsyn mutations in 16 unrelated patients with a congenital/hereditary myasthenic syndrome were identified, and a mutation (N88K) common to each of them was found. Two distinct phenotypes were noted: early and late onset. The former is frequently associated with arthrogryposis multiplex congenita and life-threatening crises. The late-onset phenotype developed in adolescence or adulthood and was initially mistaken for seronegative myasthenia gravis. Recognition of this late-onset phenotype should prevent inappropriate immunotherapy.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14504330     DOI: 10.1212/01.wnl.0000085865.55513.ae

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  24 in total

1.  Mutations in the embryonal subunit of the acetylcholine receptor (CHRNG) cause lethal and Escobar variants of multiple pterygium syndrome.

Authors:  Neil V Morgan; Louise A Brueton; Phillip Cox; Marie T Greally; John Tolmie; Shanaz Pasha; Irene A Aligianis; Hans van Bokhoven; Tamas Marton; Lihadh Al-Gazali; Jenny E V Morton; Christine Oley; Colin A Johnson; Richard C Trembath; Han G Brunner; Eamonn R Maher
Journal:  Am J Hum Genet       Date:  2006-06-20       Impact factor: 11.025

Review 2.  Muscle-Specific Tyrosine Kinase and Myasthenia Gravis Owing to Other Antibodies.

Authors:  Michael H Rivner; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; Lin Mei
Journal:  Neurol Clin       Date:  2018-05       Impact factor: 3.806

Review 3.  Arthrogryposis: a review and update.

Authors:  Michael Bamshad; Ann E Van Heest; David Pleasure
Journal:  J Bone Joint Surg Am       Date:  2009-07       Impact factor: 5.284

4.  An ocular motility conundrum.

Authors:  Elizabeth Margaret McElnea; Kirk Stephenson; Bernie Lanigan; Ian Flitcroft
Journal:  BMJ Case Rep       Date:  2014-10-27

Review 5.  Current status of the congenital myasthenic syndromes.

Authors:  Andrew G Engel
Journal:  Neuromuscul Disord       Date:  2011-11-21       Impact factor: 4.296

Review 6.  Congenital Myasthenic Syndromes: a Clinical and Treatment Approach.

Authors:  Constantine Farmakidis; Mamatha Pasnoor; Richard J Barohn; Mazen M Dimachkie
Journal:  Curr Treat Options Neurol       Date:  2018-07-21       Impact factor: 3.598

7.  Common founder effect of rapsyn N88K studied using intragenic markers.

Authors:  Vanessa Dunne; Ricardo A Maselli
Journal:  J Hum Genet       Date:  2004-06-08       Impact factor: 3.172

8.  Myasthenic syndrome due to defects in rapsyn: Clinical and molecular findings in 39 patients.

Authors:  M Milone; X M Shen; D Selcen; K Ohno; J Brengman; S T Iannaccone; C M Harper; A G Engel
Journal:  Neurology       Date:  2009-07-21       Impact factor: 9.910

9.  Dok-7 myasthenia: phenotypic and molecular genetic studies in 16 patients.

Authors:  Duygu Selcen; Margherita Milone; Xin-Ming Shen; C Michel Harper; Anthony A Stans; Eric D Wieben; Andrew G Engel
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

Review 10.  The emerging diversity of neuromuscular junction disorders.

Authors:  J Newsom-Davis
Journal:  Acta Myol       Date:  2007-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.